THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Renovis shareholders approve acquisition by Evotec

Email|Print|Single Page| Text size – +
May 1, 2008

SOUTH SAN FRANCISCO, Calif.—Renovis Inc. said Thursday that its stockholders have approved the biopharmaceutical company's acquisition by German drug maker Evotec AG at a special meeting.

The acquisition is expected to close by Monday.

The all-stock deal was valued at about $151.8 million when it was announced in September 2007.

Renovis shares gained 1 cent to $2.27 in afternoon trading. The stock has lost more than 30 percent from its closing price of $3.32 before the deal was announced.

© Copyright 2008 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

more stories like this

  • Email
  • Email
  • Print
  • Print
  • Single page
  • Single page
  • Reprints
  • Reprints
  • Share
  • Share
  • Comment
  • Comment
 
  • Share on DiggShare on Digg
  • Tag with Del.icio.us Save this article
  • powered by Del.icio.us
Your Name Your e-mail address (for return address purposes) E-mail address of recipients (separate multiple addresses with commas) Name and both e-mail fields are required.
Message (optional)
Disclaimer: Boston.com does not share this information or keep it permanently, as it is for the sole purpose of sending this one time e-mail.